Sprint Bioscience Medicinal Chemistry team is pleased to announce that Dr. Fredrik Rahm will join us from AstraZeneca in the position as Principal Scientist starting December 1. Fredrik will strengthen Sprint Bioscience by bringing several years of fragment based drug discovery experience into our team. Welcome Fredrik!
